KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pacific Biosciences Of California (PACB) Shares Outstanding (Diluted Average) (2020 - 2025)

Pacific Biosciences Of California has reported Shares Outstanding (Diluted Average) over the past 7 years, most recently at $300.0 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $300.0 million for Q4 2025, up 4.02% from a year ago — trailing twelve months through Dec 2025 was $300.0 million (up 4.02% YoY), and the annual figure for FY2025 was $300.0 million, up 4.02%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $300.0 million at Pacific Biosciences Of California, roughly flat from $299.3 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for PACB hit a ceiling of $300.2 million in Q2 2025 and a floor of $196.7 million in Q2 2021.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $254.3 million (2023), compared with a mean of $255.0 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): rose 28.36% in 2021 and later increased 4.02% in 2025.
  • Pacific Biosciences Of California's Shares Outstanding (Diluted Average) stood at $204.1 million in 2021, then rose by 10.0% to $224.6 million in 2022, then increased by 12.95% to $253.6 million in 2023, then increased by 13.7% to $288.4 million in 2024, then increased by 4.02% to $300.0 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $300.0 million (Q4 2025), $299.3 million (Q3 2025), and $300.2 million (Q2 2025) per Business Quant data.